Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(2)

Detailed Status

Completed2
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed250%
terminated125%
withdrawn125%

Recent Activity

0 active trials
Showing 4 of 4
terminatednot_applicable

Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Early Feasibility Trial

NCT02799823
completednot_applicable

Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Feasibility Trial CANADA

NCT02838680
completednot_applicable

HLT transfemOral Replacement of aortIc Valve Via transcatherteriZatiON

NCT02157142
withdrawnnot_applicable

HLT transfemOral Replacement of aortIc Valve Via transcatherteriZatiON CANADA

NCT02159794

Clinical Trials (4)

Showing 4 of 4 trials
NCT02799823Not Applicable

Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Early Feasibility Trial

Terminated
NCT02838680Not Applicable

Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Feasibility Trial CANADA

Completed
NCT02157142Not Applicable

HLT transfemOral Replacement of aortIc Valve Via transcatherteriZatiON

Completed
NCT02159794Not Applicable

HLT transfemOral Replacement of aortIc Valve Via transcatherteriZatiON CANADA

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4